AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

Compare

5.63

-0.14 (-2.43%)

At close: Oct 28, 2025, 4:00 PM EDT

5.62

-0.01 (-0.18%)

Pre-market: Oct 29, 2025, 4:44 AM EDT

AbCellera Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	32.88	28.83	38.03	485.42	375.2	233.16	Upgrade
Revenue Growth (YoY)	-0.54%	-24.17%	-92.17%	29.38%	60.92%	1907.88%	Upgrade
Cost of Revenue	168.76	167.26	175.66	174.32	107.58	56.54	Upgrade
Gross Profit	-135.88	-138.43	-137.63	311.11	267.63	176.62	Upgrade
Selling, General & Admin	82.5	85.49	75.18	66.76	48.76	15.75	Upgrade
Operating Expenses	110.78	144.34	99.57	86.2	63.21	20.59	Upgrade
Operating Income	-246.66	-282.77	-237.21	224.91	204.41	156.03	Upgrade
Interest Expense	-	-	-	-	-	-6.81	Upgrade
Interest & Investment Income	33.91	38.47	42.25	16.08	3.33	0.29	Upgrade
Other Non Operating Income (Expenses)	-18.74	11.2	13.1	8.21	11.91	8.32	Upgrade
EBT Excluding Unusual Items	-231.49	-233.1	-181.86	249.2	219.65	157.83	Upgrade
Gain (Loss) on Sale of Investments	17.4	17.4	3.9	-1.7	-0.5	-	Upgrade
Asset Writedown	-32	-32	-	-8.4	-	-	Upgrade
Other Unusual Items	47.3	47.3	3.93	-	-	-	Upgrade
Pretax Income	-198.79	-200.4	-174.03	239.1	219.15	157.83	Upgrade
Income Tax Expense	-33.12	-37.54	-27.63	80.58	65.69	38.92	Upgrade
Net Income	-165.67	-162.86	-146.4	158.52	153.46	118.92	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-	33.82	Upgrade
Net Income to Common	-165.67	-162.86	-146.4	158.52	153.46	85.1	Upgrade
Net Income Growth	-	-	-	3.29%	29.05%	-	Upgrade
Shares Outstanding (Basic)	297	294	289	285	276	159	Upgrade
Shares Outstanding (Diluted)	297	294	289	315	318	263	Upgrade
Shares Change (YoY)	1.69%	1.79%	-8.15%	-1.09%	20.96%	73.88%	Upgrade
EPS (Basic)	-0.56	-0.55	-0.51	0.56	0.56	0.53	Upgrade
EPS (Diluted)	-0.56	-0.55	-0.51	0.50	0.48	0.45	Upgrade
EPS Growth	-	-	-	4.17%	6.21%	-	Upgrade
Free Cash Flow	-138.99	-186.95	-120.82	206.7	186.13	13.02	Upgrade
Free Cash Flow Per Share	-0.47	-0.64	-0.42	0.66	0.58	0.05	Upgrade
Gross Margin	-	-	-	64.09%	71.33%	75.75%	Upgrade
Operating Margin	-750.29%	-980.70%	-623.82%	46.33%	54.48%	66.92%	Upgrade
Profit Margin	-503.91%	-564.83%	-385.00%	32.66%	40.90%	36.50%	Upgrade
Free Cash Flow Margin	-422.76%	-648.40%	-317.75%	42.58%	49.61%	5.58%	Upgrade
EBITDA	-218.38	-223.92	-212.81	244.35	218.88	160.87	Upgrade
EBITDA Margin	-	-	-	50.34%	58.34%	69.00%	Upgrade
D&A For EBITDA	28.29	58.85	24.4	19.44	14.47	4.84	Upgrade
EBIT	-246.66	-282.77	-237.21	224.91	204.41	156.03	Upgrade
EBIT Margin	-	-	-	46.33%	54.48%	66.92%	Upgrade
Effective Tax Rate	-	-	-	33.70%	29.97%	24.66%	Upgrade
Revenue as Reported	32.88	28.83	38.03	485.42	375.2	233.16	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q